The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Research Report 2025
Synopsis
The global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment.
Report Scope
The B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Bayer
Bristol-Myers Squibb
Merck Serono
Roche
AstraZeneca
AbbVie
Novartis
Segment by Type
Chemotherapy
Radiation Therapy
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment.
Report Scope
The B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Bayer
Bristol-Myers Squibb
Merck Serono
Roche
AstraZeneca
AbbVie
Novartis
Segment by Type
Chemotherapy
Radiation Therapy
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chemotherapy
1.2.3 Radiation Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Perspective (2019-2030)
2.2 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Growth Trends by Region
2.2.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Historic Market Size by Region (2019-2024)
2.2.3 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Region (2025-2030)
2.3 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Dynamics
2.3.1 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Industry Trends
2.3.2 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Drivers
2.3.3 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Challenges
2.3.4 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Players by Revenue
3.1.1 Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Players by Revenue (2019-2024)
3.1.2 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Players (2019-2024)
3.2 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue
3.4 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Concentration Ratio
3.4.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue in 2023
3.5 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Key Players Head office and Area Served
3.6 Key Players B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product Solution and Service
3.7 Date of Enter into B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Breakdown Data by Type
4.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Historic Market Size by Type (2019-2024)
4.2 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Type (2025-2030)
5 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Breakdown Data by Application
5.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Historic Market Size by Application (2019-2024)
5.2 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2019-2030)
6.2 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2019-2024)
6.4 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2019-2030)
7.2 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2019-2024)
7.4 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2019-2030)
8.2 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2019-2030)
9.2 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2019-2024)
9.4 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2019-2030)
10.2 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.1.4 Amgen Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024)
11.1.5 Amgen Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.2.4 Bayer Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024)
11.2.5 Bayer Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Merck Serono
11.4.1 Merck Serono Company Detail
11.4.2 Merck Serono Business Overview
11.4.3 Merck Serono B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.4.4 Merck Serono Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024)
11.4.5 Merck Serono Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.5.4 Roche Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024)
11.5.5 Roche Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.6.4 AstraZeneca Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024)
11.6.5 AstraZeneca Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Detail
11.7.2 AbbVie Business Overview
11.7.3 AbbVie B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.7.4 AbbVie Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024)
11.7.5 AbbVie Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.8.4 Novartis Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024)
11.8.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Others
Table 5. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Region (2019-2024)
Table 9. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Region (2025-2030)
Table 11. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Trends
Table 12. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Drivers
Table 13. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Challenges
Table 14. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Restraints
Table 15. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Players (2019-2024)
Table 17. Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment as of 2023)
Table 18. Ranking of Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product Solution and Service
Table 22. Date of Enter into B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Type (2019-2024)
Table 26. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Type (2025-2030)
Table 28. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Application (2019-2024)
Table 30. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Application (2025-2030)
Table 32. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 47. Amgen Company Detail
Table 48. Amgen Business Overview
Table 49. Amgen B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
Table 50. Amgen Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024) & (US$ Million)
Table 51. Amgen Recent Development
Table 52. Bayer Company Detail
Table 53. Bayer Business Overview
Table 54. Bayer B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
Table 55. Bayer Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024) & (US$ Million)
Table 56. Bayer Recent Development
Table 57. Bristol-Myers Squibb Company Detail
Table 58. Bristol-Myers Squibb Business Overview
Table 59. Bristol-Myers Squibb B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
Table 60. Bristol-Myers Squibb Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024) & (US$ Million)
Table 61. Bristol-Myers Squibb Recent Development
Table 62. Merck Serono Company Detail
Table 63. Merck Serono Business Overview
Table 64. Merck Serono B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
Table 65. Merck Serono Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024) & (US$ Million)
Table 66. Merck Serono Recent Development
Table 67. Roche Company Detail
Table 68. Roche Business Overview
Table 69. Roche B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
Table 70. Roche Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024) & (US$ Million)
Table 71. Roche Recent Development
Table 72. AstraZeneca Company Detail
Table 73. AstraZeneca Business Overview
Table 74. AstraZeneca B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
Table 75. AstraZeneca Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024) & (US$ Million)
Table 76. AstraZeneca Recent Development
Table 77. AbbVie Company Detail
Table 78. AbbVie Business Overview
Table 79. AbbVie B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
Table 80. AbbVie Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024) & (US$ Million)
Table 81. AbbVie Recent Development
Table 82. Novartis Company Detail
Table 83. Novartis Business Overview
Table 84. Novartis B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
Table 85. Novartis Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024) & (US$ Million)
Table 86. Novartis Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Type: 2023 VS 2030
Figure 3. Chemotherapy Features
Figure 4. Radiation Therapy Features
Figure 5. Others Features
Figure 6. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Others Case Studies
Figure 12. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Report Years Considered
Figure 13. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Region: 2023 VS 2030
Figure 16. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Players in 2023
Figure 17. Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue in 2023
Figure 19. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Country (2019-2030)
Figure 21. United States B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Country (2019-2030)
Figure 25. Germany B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Region (2019-2030)
Figure 33. China B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Country (2019-2030)
Figure 41. Mexico B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Country (2019-2030)
Figure 45. Turkey B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Amgen Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024)
Figure 48. Bayer Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024)
Figure 49. Bristol-Myers Squibb Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024)
Figure 50. Merck Serono Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024)
Figure 51. Roche Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024)
Figure 52. AstraZeneca Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024)
Figure 53. AbbVie Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024)
Figure 54. Novartis Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
